The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase 3 study evaluating efficacy and safety of veliparib (V) plus carboplatin (Cb) or Cb in combination with standard neoadjuvant chemotherapy (NAC) in patients (pts) with early stage triple-negative breast cancer (TNBC).
 
Charles E. Geyer
Consulting or Advisory Role - Myriad Genetics; Stemnion
Research Funding - Incyte; Merck
Travel, Accommodations, Expenses - Abbvie; AstraZeneca; Genentech/Roche
 
Joyce O'Shaughnessy
Honoraria - Abbvie; Arno Therapeutics; AstraZeneca; Celgene; Eisai; Genentech/Roche; Lilly; Nektar; Novartis; Pfizer
Consulting or Advisory Role - Abbvie; Arno Therapeutics; AstraZeneca; Celgene; Eisai; Genentech/Roche; Lilly; Nektar; Novartis; Pfizer
Travel, Accommodations, Expenses - Abbvie; Celgene; Lilly; Nektar; Novartis; Pfizer
 
Michael Untch
No Relationships to Disclose
 
William Sikov
Consulting or Advisory Role - Abbvie
 
Hope S. Rugo
Honoraria - Genomic Health
Speakers' Bureau - Genomic Health
Research Funding - Celsion (Inst); Clovis Oncology (Inst); Eisai (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Lilly (Inst); Macrogenics (Inst); Merck (Inst); Novartis (Inst); OBI Pharma (Inst); Pfizer (Inst); Plexxikon (Inst)
Travel, Accommodations, Expenses - Bayer; Novartis; OBI Pharma; Pfizer; Roche/Genentech
 
Mark D. McKee
Employment - Abbvie
Stock and Other Ownership Interests - Abbvie
 
Jens Bodo Huober
Honoraria - Abbvie; AstraZeneca; Sanofi
 
Mehra Golshan
No Relationships to Disclose
 
Vincent L. Giranda
Employment - Abbvie
Stock and Other Ownership Interests - Abbvie
 
Gunter Von Minckwitz
Research Funding - Abbvie (Inst); Amgen (Inst); AstraZeneca (Inst); Celgene (Inst); Myriad Genetics (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst); Sanofi (Inst); Teva (Inst); Vifor Pharma (Inst)
 
David Maag
Employment - Abbvie
Stock and Other Ownership Interests - Abbvie
 
Danielle Marie Sullivan
Employment - Abbvie
Stock and Other Ownership Interests - Abbvie
 
Norman Wolmark
No Relationships to Disclose
 
Kristi McIntyre
No Relationships to Disclose
 
Jose Juan Ponce Lorenzo
No Relationships to Disclose
 
Otto Metzger Filho
No Relationships to Disclose
 
Priya Rastogi
No Relationships to Disclose
 
William Fraser Symmans
Stock and Other Ownership Interests - ISIS Pharmaceuticals; Nuvera Biosciences
Honoraria - Affymetrix; Australasian Society for Breast Disease; Celgene
Consulting or Advisory Role - Roche/Genentech
Patents, Royalties, Other Intellectual Property - Intellectual Property
Travel, Accommodations, Expenses - Abbvie
 
Xuan Liu
Employment - Abbvie
Stock and Other Ownership Interests - Abbvie
 
Sibylle Loibl
Consulting or Advisory Role - Abbvie